Explore COVID-19 Publications
A lot of research articles concerning SARS-CoV-2/COVID-19 are published every day. Many of them, so-called pre-prints, are not reviewed in a professional reviewing process at the time of publication. Others are already reviewed and published in well-known journals. Collabovid helps researchers to identify the most relevant information by using Natural Language Processing. You can search for any topic you want below. Visit search to review all articles or browse a list of predefined categories. For additional help visit the frequently asked questions.

Helping researchers
Since January 2020, 63534 articles concerning the coronavirus were indexed by our service. Of these publications, 0 appeared today and 40 have been released in the past week. For researchers, it is impossible to review every single one manually. Therefore, Natural Language Processing techniques are needed to filter out the most relevant information and allow researchers to make faster progress in fighting the crisis.

Find Relevant Research

Map

Visual Exploration

Topic Extraction

Analyze your Literature

Are you an Expert?
Categories for papers from Jan. 22, 2021
Categories for the currently trending papers
Categories for the most popular papers
-
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
April 3, 2020 · Elsevier · Added 8 months ago Read more -
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
Aug. 7, 2020 · Elsevier · Added 5 months, 3 weeks ago Read more -
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Sept. 4, 2020 · Elsevier · Added 4 months, 3 weeks ago Read more -
Excess mortality associated with the COVID-19 pandemic among Californians 18-65 years of age, by occupational sector and occupation: March through October 2020
Jan. 22, 2021 · medRxiv · Added 4 days, 6 hours ago Read more -
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Dec. 8, 2020 · Elsevier · Added 3 weeks, 4 days ago Read more